Hutchison China Meditech Ltd has expanded its drug discovery and development partnership with Eli Lilly, adding another oncology target to the agenda. When the two companies set up their partnership last year, the initial areas of concentration were specified targets in oncology and inflammation. More details...

Stock Symbols: (LSE: HCM) (NYSE: LLY)